How does the USPTO handle confidentiality of sequence data in pending applications?

The USPTO maintains strict confidentiality of sequence data in pending applications, in compliance with 35 U.S.C. 122. The MPEP clarifies: It should be noted that the Office’s database complies with the confidentiality requirement imposed by 35 U.S.C. 122. Unpublished pending application sequences are maintained in the database separately from published or patented sequences. That is,…

Read More

What are the main parts of a “Sequence Listing XML”?

The main parts of a “Sequence Listing XML” are: XML declaration DOCTYPE declaration Root element General information part Sequence data part As specified in MPEP 2413.01, “The constituent parts of the ‘Sequence Listing XML’ are identified in multiple paragraphs of WIPO Standard ST.26 and have been specifically incorporated into the USPTO rules of practice at…

Read More

Are there alternative ways to access sequence data from patents and patent applications?

Yes, there are alternative ways to access sequence data from patents and patent applications: Through the National Center for Biotechnology Information (NCBI) at www.ncbi.nlm.nih.gov. From commercial vendors. The MPEP explains: Sequence data may also be accessed in a more readily searchable manner from the National Center for Biotechnology Information (NCBI) at www.ncbi.nlm.nih.gov or from a…

Read More